HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Mitsune Tanimoto Selected Research
Mitsune Tanimoto Research Topics
Disease
77
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2020 - 03/2002
71
Neoplasms (Cancer)
02/2022 - 03/2002
62
Lung Neoplasms (Lung Cancer)
10/2017 - 03/2002
26
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
10/2016 - 05/2002
19
Inflammation (Inflammations)
01/2019 - 04/2005
15
Leukemia
01/2017 - 04/2002
14
Graft vs Host Disease (Graft-Versus-Host Disease)
02/2018 - 04/2002
13
Lymphoma (Lymphomas)
10/2014 - 04/2002
11
Disease Progression
11/2017 - 05/2005
11
Respiratory Hypersensitivity
06/2016 - 04/2005
10
Interstitial Lung Diseases (Interstitial Lung Disease)
06/2010 - 03/2003
10
Adenocarcinoma
01/2009 - 03/2002
9
Neoplasm Metastasis (Metastasis)
07/2020 - 03/2002
9
Asthma (Bronchial Asthma)
12/2017 - 09/2006
9
BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
11/2017 - 01/2003
8
Bronchiolitis Obliterans Syndrome
01/2017 - 02/2007
8
Febrile Neutropenia
01/2015 - 01/2004
8
Infections
05/2014 - 08/2002
7
Hematologic Neoplasms (Hematological Malignancy)
08/2017 - 01/2004
7
Fibrosis (Cirrhosis)
01/2012 - 03/2003
6
Pneumonia (Pneumonitis)
11/2016 - 05/2005
6
Malignant Pleural Effusion
10/2014 - 02/2007
5
B-Cell Lymphoma (Lymphoma, B Cell)
09/2021 - 12/2002
5
Emphysema
01/2019 - 01/2013
5
Pleural Effusion (Pleural Effusions)
06/2017 - 08/2011
5
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2017 - 06/2004
5
Fever (Fevers)
08/2016 - 08/2002
5
Carcinogenesis
08/2016 - 09/2008
5
Adenocarcinoma of Lung
10/2014 - 07/2005
5
Neutropenia
08/2012 - 07/2004
4
Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2017 - 01/2003
4
Carcinoma (Carcinomatosis)
01/2017 - 10/2002
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
08/2015 - 04/2009
4
Hyperplasia
07/2014 - 04/2005
4
Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
05/2014 - 12/2003
4
Squamous Cell Carcinoma (Epidermoid Carcinoma)
09/2011 - 03/2002
3
Brain Neoplasms (Brain Tumor)
07/2020 - 11/2004
3
Pulmonary Emphysema
01/2019 - 01/2013
3
T-Cell Lymphoma (Lymphoma, T Cell)
12/2017 - 04/2014
Drug/Important Bio-Agent (IBA)
43
Gefitinib (Iressa)
FDA Link
11/2016 - 04/2003
38
ErbB Receptors (EGF Receptor)
IBA
07/2020 - 01/2004
36
Cisplatin (Platino)
FDA Link
Generic
10/2016 - 03/2002
26
Tyrosine Kinase Inhibitors
IBA
11/2017 - 01/2004
15
Irinotecan (Camptosar)
FDA Link
Generic
07/2012 - 01/2003
11
Docetaxel (Taxotere)
FDA Link
04/2012 - 07/2004
10
Pharmaceutical Preparations
IBA
04/2022 - 06/2002
10
Doxorubicin (Adriamycin)
FDA Link
Generic
12/2017 - 01/2003
10
Antigens
IBA
01/2017 - 08/2002
9
Carboplatin (JM8)
FDA Link
Generic
10/2017 - 05/2002
9
Cytokines
IBA
06/2016 - 03/2002
8
Ovalbumin
IBA
12/2017 - 09/2006
8
Etoposide (VP 16)
FDA Link
Generic
12/2017 - 05/2002
8
Imatinib Mesylate (Gleevec)
FDA Link
06/2017 - 05/2007
8
Proteins (Proteins, Gene)
FDA Link
06/2016 - 11/2002
8
Erlotinib Hydrochloride (CP 358,774)
FDA Link
01/2016 - 01/2010
7
Platinum
IBA
01/2017 - 06/2002
7
Allergens
IBA
01/2014 - 09/2006
6
Rituximab (Mabthera)
FDA Link
09/2021 - 11/2007
6
Pancreatic Elastase (Elastase)
IBA
01/2019 - 01/2013
6
Indicators and Reagents (Reagents)
IBA
11/2017 - 10/2002
6
Ifosfamide
FDA Link
Generic
05/2009 - 03/2002
6
DNA (Deoxyribonucleic Acid)
IBA
09/2008 - 08/2003
6
Interleukin-8 (Interleukin 8)
IBA
07/2007 - 01/2003
6
Urokinase-Type Plasminogen Activator (Urokinase)
FDA Link
07/2007 - 10/2002
5
Cyclophosphamide (Cytoxan)
FDA Link
Generic
12/2017 - 06/2007
5
Topotecan (Hycamtin)
FDA Link
Generic
10/2016 - 06/2006
5
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
08/2016 - 09/2002
5
Biomarkers (Surrogate Marker)
IBA
01/2015 - 09/2008
5
Messenger RNA (mRNA)
IBA
07/2014 - 04/2002
5
Paclitaxel (Taxol)
FDA Link
Generic
05/2014 - 07/2004
5
amrubicin
IBA
07/2012 - 05/2005
4
Vincristine (Oncovin)
FDA Link
Generic
12/2017 - 05/2008
4
Prednisone (Sone)
FDA Link
Generic
12/2017 - 01/2006
4
Reactive Oxygen Species (Oxygen Radicals)
IBA
03/2017 - 10/2002
4
Bevacizumab (Avastin)
FDA Link
01/2017 - 05/2013
4
Afatinib
IBA
01/2017 - 05/2013
4
Interleukin-2 (IL2)
IBA
01/2017 - 03/2002
4
Phosphotransferases (Kinase)
IBA
03/2016 - 01/2004
4
Chemokines
IBA
04/2015 - 07/2005
4
Paraffin
IBA
09/2014 - 04/2009
4
Anti-Bacterial Agents (Antibiotics)
IBA
06/2014 - 01/2004
4
Vindesine (Vindesin)
IBA
06/2011 - 03/2002
4
Fluorouracil (Carac)
FDA Link
Generic
01/2011 - 03/2003
4
Gemcitabine
FDA Link
04/2008 - 03/2006
3
Interleukin-17 (Interleukin 17)
IBA
01/2019 - 01/2013
3
Chemotactic Factors
IBA
01/2019 - 01/2003
3
Tacrolimus (Prograf)
FDA Link
Generic
02/2018 - 06/2006
3
Anaplastic Lymphoma Kinase
IBA
12/2017 - 03/2016
Therapy/Procedure
63
Drug Therapy (Chemotherapy)
09/2021 - 03/2002
47
Therapeutics
02/2022 - 08/2002
13
Hematopoietic Stem Cell Transplantation
01/2017 - 04/2002
12
Radiotherapy
10/2016 - 05/2002
12
Cell Transplantation
10/2016 - 06/2004
10
Transplantation
08/2017 - 09/2003
9
Chemoradiotherapy
03/2018 - 12/2003
9
Combination Drug Therapy (Combination Chemotherapy)
01/2012 - 03/2002
7
Bone Marrow Transplantation (Transplantation, Bone Marrow)
02/2014 - 01/2005
5
Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
05/2006 - 08/2002
4
Aftercare (After-Treatment)
02/2022 - 10/2006
4
Adjuvant Chemotherapy
01/2012 - 10/2004